AIM
TAK icon

ARK Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

ARK Investment Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,862,379
Closed -$107M – 392
2021
Q4 		$107M Sell
7,862,379
-5,639,271
-42% -$79.1M 0.32% 55
2021
Q3 		$221M Sell
13,501,650
-1,991,347
-13% -$33.4M 0.53% 42
2021
Q2 		$261M Sell
15,492,997
-3,224,147
-17% -$54.9M 0.49% 53
2021
Q1 		$342M Buy
18,717,144
+10,098,979
+117% +$182M 0.68% 46
2020
Q4 		$157M Buy
8,618,165
+7,461,868
+645% +$131M 0.42% 59
2020
Q3 		$20.6M Buy
+1,156,297
New +$21.1M 0.12% 89

Other funds holding TAK

PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return